Home Study Details

    Program Type

    Home Study Webcast


    1 Contact Hour(s)

    Release Date

    Friday, December 2, 2022

    Offline Date

    Saturday, March 29, 2025

    ACPE Expiration Date

    Monday, September 29, 2025

    Target Audience

    Pharmacy Technician



    • Overview

      Glucagon like peptide 1 agonists (GLP-1) are used in treating type 2 diabetes and for the achievement of weight loss. Obesity has been associated with an increased risk of developing type 2 diabetes. Furthermore, American Diabetes Association (ADA) estimates that more than 90% of patients who are overweight or obese are aslo diagnosed with type 2 diabetes. The recently updated ADA 2022 guidelines recommend choosing first line medications based on patient’s concurrent diseases. Therefore, in this session we will review the difference between GLP-1 agonists and their role in type 2 diabetes and obesity. Additionally, after the webinar pharmacy technicians will be able to recognize the GLP-1 agonist injection techniques, their storage and list some of the common available patient assistance programs.


      • Slide Document :   22159H01_2pp.pdf
      • Slide Document :   22159H01_6pp.pdf

      Financial Support By

    • Pharmacy Technician

      Identify appropriate GLP-1 agonist injection techniques
      List important clinical considerations for GLP-1 agonists
      Compare and contrast the differences between GLP-1 agonists
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacy Technician 0798-0000-22-259-H01-T

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).